52
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium

, , , &
Pages 123-126 | Published online: 07 Mar 2008

References

  • American Thoracic SocietyStandardization of spirometry: 1994 updateAm J Respir Crit Care Med19951521107367663792
  • BarnesPJMuscarinic receptor subtypes in airwaysLife Sci199352521278441331
  • BarnesPJChronic obstructive pulmonary diseaseN Engl J Med20003432698010911010
  • BarrRGBourbeauJCamargoCAInhaled tiotropium for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev2005CD00287615846642
  • BrusascoVHodderRMiravitllesMHealth outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax20035839940412728159
  • CasaburiRBriggsDDJrDonohueJFThe spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study GroupChest2000118129430211083677
  • CazzolaMNoschesePSalzilloABronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patientsRespir Med2005995242815823447
  • DahlRBackerVOllgaardBAssessment of patients performance of the HandiHaler compared with the metered dose inhaler four weeks after instructionsRespir Med20039711263314561020
  • DonaldsonGCSeemungalTARBhowmikARelationship between exacerbations frequency and lung function decline in chronic obstructive lung diseaseThorax2002578475212324669
  • Garcia-AymerichJMonsoEMarradesRMRisk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM studyAm J Respir Crit Care Med20011641002711587986
  • HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med200435026455315215480
  • IncorvaiaCRiario-SforzaGGPravettoniCEffects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: a randomized studyRespir Med20071014768016919926
  • KannerREAnthonisenNRConnettJELower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20011643586411500333
  • MurrayCJLopezADAlternative projection of mortality by cause 1990–2020: global burden of disease studyLancet199734914985049167458
  • PauwelsRCalverleyPBuistASCOPD exacerbations: the importance of a standard definitionRespir Med2004989910714971871
  • PhuaGCMacintyreNRInhaled corticosteroids in obstructive airway diseaseRespir Care200752852817594729
  • PowrieDJWilkinsonTMDonaldsonGCEffect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPDEur Respir J200730472817504798
  • RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summaryAm J Respir Crit Care Med20071765325517507545
  • Riario-SforzaGGIncorvaiaCPaternitiFDifferent outcomes of pulmonary rehabilitation in patients with COPD with or without exacerbationsMonaldi Arch Chest Dis2005631293216312202
  • SutherlandERCherniakRMManagement of chronic obstructive pulmonary diseaseN Engl J Med200435026899715215485
  • The National Collaborating Centre for Chronic ConditionsNational clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary careThorax200459suppl 11232